semaj83/ctmatch_classification huggingface dataset:
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Diarrhea, Secretory Children presented with secretory diarrhea(acute watery diarrhea) attend to out clinic lab of Assiut University pediatric hospital or admitted in pediatric hospital(gastroenterology department) during the study period. 2. adult patients having acute watery diarrhea attend to out clinic labs of Assiut University hospital or admitted in gastroenterology, nephrology and oncology department of hospital during the study period  viral and bacterial causes of diarrhea 2. Patients who were already diagnosed as intestinal inflammatory disease as irritable bowel syndrome. 3. Autoimmune conditions, such as ulcerative colitis, Crohn's disease and coeliac disease
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-70.0,  Surgical View Shoulder Tip Pain Abdominal Pain Age 18-70 years Ability to give informed consent Patients who are approved by the anaesthetics to undergo bariatric surgery  Age below 18 and above 70 Inability to give informed consent Patient unfit for bariatric surgery including who has poor respiratory, cardiac, renal and liver function Patient with Body Mass Index (BMI) >50 Patient with American Society of Anesthesiologists (ASA) >3
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Acute Coronary Syndrome A subject with a symptomatology consistent with acute coronary syndrome for at least 15 min and less than 6 hours (eg discomfort, tightness or chest pain, pain radiating to the left arm or both arms, pain in the jaw, Pain in the back / neck / stomach, dyspnea, cold sweats, nausea / vomiting, dizziness) Man or woman over 18 years Patient agreeing to participate in the study and having signed informed consent  Minor Patient Patient not having signed informed consent (refusal, physical or mental incapacity ...) --Patient with an evolutive septic process, neoplasia undergoing treatment, dialysed renal insufficiency, history of surgery or coronary angioplasty less than six months old. Cardiac, renal or hepatic transplantation elevation of troponin Cardiac arrest A subject whose symptomatology clearly eliminates acute coronary syndrome (penetrating trauma, traumatic lesion by crushing ...) Patient who died between the time of and arrival in cardiology intensive care (ICU) Patient withdrawing consent during study Vulnerable people unable to fully integrate the objectives, benefits and risks of research and to give their informed consent Pregnant women Persons deprived of their liberty
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Postoperative Pain any patient > 18 years of age scheduled for primary total hip or knee arthroplasty who is not consuming opioids during the 4 weeks prior to surgery  patients consuming opioids during the 4 weeks prior to surgery patients who are allergic to oxycodone or refuse to take oxycodone patients with a history of opioid dependence or illegal or "off-label" opioid use patients undergoing a revision total knee or total hip arthroplasty any patient less than 18 years of age
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 16.0-60.0,  Safety of the Oral O1 / O139 Cholera Vaccine (Enteric Capsules) Healthy adults aged 16-60 years old as established by medical history and clinical examination The subjects' guardians are able to understand and sign the informed consent Subjects who can and will comply with the requirements of the protocol Hemoglobin: 110-150g/L (female), 120-160g/L (male) Leukocyte count: 4.0-10.0×109 /L Lymphocyte count: 0.8-4.5×109 /L Platelet count: 100-300×109/L Alanine aminotransferase: (ALT)0-40U/L Serum creatinine: 44-106μmol/L Subjects with temperature ≤37.0°C on axillary setting  Pregnant or lactating women Subject that has a medical history of any of the following: allergic history, or allergic to any ingredient of vaccine Have serious side effects to vaccine, such as allergies, hives, breathing difficulties, angioneurotic oedema or abdominal pain abdominal pain or diarrhea asthma, in the past two years, unsteady and require emergency treatment, hospitalization, intubation, oral administration or intravenous corticosteroids Diabetes (type I or II), not including gestational diabetes Thyroid disease Serious angioneurotic edema in the past three years, or in need of treatment in the past 2 years Hypertension, over 145/95 mmHg Blood coagulation disorder (such as the lack of clotting factors, clotting hemorrhagic disease, abnormal platelet) or apparent bruises or blood coagulation disorder
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Irritable Bowel Syndrome With Diarrhea Irritable Bowel Syndrome With Mixed Bowel Habits Adults (18+ years or older) with a diagnosis of IBS-D or IBS-M based on Rome IV Diarrhea must occur 2 or more days per week Patients on current pharmacological therapy for their gastrointestinal complaints can enroll in the study as long as they have been on a stable dose for at least 30 days  Significant comorbidities that are associated with GI symptoms (e.g. diabetes, scleroderma, SLE), history of GI surgery excluding appendectomy, or prior organic GI illness Antibiotics taken in the past 2 months Current disordered eating patterns (diagnosed eating disorder; as per verbal ESP questionnaire) Current history of greater than moderate alcohol intake (more than 1 drink per day for women, more than 2 drinks per day for men, binge drinking behavior of 5+ drinks in a single session once per week) Cannot have had a cholecystectomy in the past 6 months prior to enrollment
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-49.0,  Cholera Capable of informed consent and provision of written informed consent before any study procedures Capable of attending all study visits according to the study schedule Are in good health, as determined by medical history and targeted physical exam related to this history Female subjects of childbearing* age must have a negative urine pregnancy test before study vaccination, and must use two forms of contraception** to avoid pregnancy within one month of Vaxchora administration  Have an acute illness within 72 hours before vaccination Have any acute or chronic medical condition that, in the opinion of the principal investigator, would make vaccination unsafe or interfere with the evaluation of immune response to study vaccination Have a suppressed immune system as a result of illness, immunosuppressive medication, chemotherapy, or radiation therapy within 3 years prior to study vaccination Have taken oral or parenteral corticosteroids of any dose within 30 days before study vaccination Reside with individuals under the age of 2 or with an immunocompromised individuals Have a known history of autoimmune disease Have a history of Guillain-Barre Syndrome Have plans to receive any vaccine from 28 days prior to study vaccination until Day 29 Has previously received a cholera vaccine or have a known history of V. Cholerae Have donated blood or blood products within 56 days before study vaccination, plan to donate blood at any time during the 56-day duration of subject study participation, or plan to donate blood within 56 days after the last blood draw
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Antibiotic-associated Diarrhea Written informed consent Male or female patient Patient aged 18 to 65 years-old Patient being prescribed broad spectrum antibiotics for a minimum period of 7 days and a maximum period of 10 days. Broad spectrum antibiotics are aminopenicillins (amoxicillin with or without clavulanic acid, ampicillin), cephalosporins (cefadroxil, cephalexin, cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone and ceftaroline), fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin), tetracyclines (doxycycline, minocycline), nitrofurans (nitrofurantoin) and/or antibacterial sulfonamides (co-trimoxazol) Patient who the investigator believes that they can and will comply with the requirements of the protocol  Patient treated with antibiotics within 3 months before in the study Pregnant or lactating woman Woman wishing to be pregnant Immunosuppressed subject Subject having a central venous catheter History of chronic diarrhoea History of irritable bowel syndrome History of Crohn's disease History of ulcerative colitis History of chronic constipation and/or chronic use of laxatives
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 0.083-17.0,  Chronic Diarrhea -all patient from 1 month up to 17 years (1month-17 year) admitted gastroenterology unit at Assuit University Children Hospital 2. Diarrhea 14 days or more ( ≥14 day)  age less than 1 month (≤1 month) 2. diarrhea less than 14 days (≤14 day) 3. chronic diarrhea due to malignancy & chemotherapy
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Chronic Diarrhea Irritable Bowel Syndrome With Diarrhea Bile Acid Malabsorption Females and males age 18 -75 An IBS diagnosis based on the Rome III for at least 3 months, with onset at least 6 months previously, of recurrent abdominal pain or discomfort Biomarkers serum alpha C4 ≥ 40 ng/mL or FGF19 ≤ 80 pg/mL or fecal bile acid >2000 micromoles/48h  IBS patients with known clinically-relevant inflammation IBS patient with known bleeding diathesis History of abdominal surgery Patients participating will not take any of the following disallowed medications for at least 7 days prior to and during the remainder of the study Any treatment specifically taken for IBS-D, including loperamide, cholestyramine, alosetron Drugs with a known pharmacological activity at 5-HT4, 5-HT2b or 5-HT3 receptors All narcotics Anti-cholinergic agents Tramadol Oral anticoagulants Antimuscarinics
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-70.0,  Celiac Disease Wheat Hypersensitivity Gluten Sensitivity Gluten Enteropathy Immune System and Related Disorders Duodenal Diseases for subjects with Celiac Disease Biopsy proven celiac disease diagnosed at least 2 years prior to recruitment Attest to following a gluten free diet to the best of their ability Quiescent symptoms on a gluten free diet Negative tissue transglutaminase at time of recruitment (to be collected with baseline blood work) A prior endoscopy with small bowel biopsies reviewed by a gastrointestinal pathologist revealing healing for subjects with Non-Celiac Gluten Sensitivity Meet diagnostic consensus as defined by Ludvigsson et al in "The Oslo definitions for coeliac disease and related terms" Attest to following a gluten free diet to the best of their ability Quiescent symptoms on a gluten free diet Prior negative evaluation for celiac disease (including tissue transglutaminase IgA with total IgA or small bowel biopsies)  Tobacco use Symptomatic coronary disease Active, severe pulmonary disease Baseline oxygen requirement Coagulopathy (INR>1.5) Mastocytosis Active H. pylori infection Treated celiac disease with neutrophilia or eosinophilia secondary to infection Diabetes (type 1 and type 2) Crohn's disease or Ulcerative colitis
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 20.0-70.0,  Cervicogenic Dizziness male or female aged between 20 and 70 neck pain and/or stiffness with dizziness, which is related to movement or positioning of cervical spine recurring symptom of dizziness over 1 month or more Dizziness Handicap Inventory ≥ 16 at baseline Informed consent  dizziness induced by vestibular disorders (e.g., benign paroxysmal positional vertigo, peripheral vestibulopathy, Meniere disease, vestibular neuronitis) dizziness induced by central nervous system (CNS) disorders (e.g., cerebellar ataxia,cerebellum infarction/hemorrhage, demyelination, vertebrobasilar insufficiency, seizure, increased intracranial pressure, Parkinson's disease, migraines) dizziness induced by cardiovascular disorders (e.g., arrhythmia, heart valvular disease, anemia, orthostatic hypotension, coronary artery disease) dizziness induced by active or uncontrolled disease (e.g., uncontrolled diabetes mellitus, hypertension, respiratory or endocrinological disorders) dizziness induced by side effects of medications severe chronic or terminal diseases (malignant cancer, tuberculosis, etc.) chronic psychiatric diseases under treatment (epilepsy, depression, panic disorder, etc.) conditions where CMT are forbidden (spinal tumor, acute fracture, infectious spondylopathy, congenital malformations of spine, operation history of spine within 3 months, progressive neurological damage, severe neurological symptoms, spinal fixation devices, syringomyelia, hydrocephaly) Treatment history within 1 week for cervicogenic dizziness (NSAIDs, steroid, herbal drug, acupuncture, manual therapy) Women of (suspected) pregnancy or breast-feeding